Estradiol Activates MAPK Signaling Pathway and Its Effects on Proliferation of Endometrial Cancer Ishikawa Cells
-
摘要: 目的 探讨雌激素是否能激活MAPK信号转导通路，以及对子宫内膜癌细胞增殖能力的影响。方法 培养子宫内膜癌Ishikawa细胞，按药物干预分为3组：雌二醇（E2）组、U0126（MAPK激酶抑制剂）+E2组、对照组。采用荧光定量PCR技术检测各组MEK1/2、ERK1/2 mRNA表达的变化；Western blot法检测各组p-MEK1/2、p-ERK1/2蛋白的活化程度；流式细胞仪检测各组的细胞周期比例；细胞集落形成实验检测各组细胞的增殖能力；体外穿膜实验比较各组细胞的迁移能力。结果 E2组MEK1/2、ERK1/2 mRNA表达增加（P=0.025, P=0.002），U0126+E2组中，U0126能阻断E2诱导MEK1/2、ERK1/2 mRNA的表达上调（P=0.000, P=0.000）。E2组p-MEK1/2、p-ERK1/2蛋白活化水平升高（P=0.049, P=0.028)；U0126+E2组中，U0126能阻断E2诱导的p-MEK1/2、p-ERK1/2蛋白活化（P=0.018, P=0.003）。E2组G1期细胞比例显著低于对照组及U0126+E2组（P=0.017），集落形成率显著高于对照组及U0126+E2组（P=0.009），穿过微孔的细胞数显著多于对照组及U0126+E2组（P=0.000）。结论 雌二醇通过激活MAPK通路，促进子宫内膜癌的发展，MEK抑制剂能阻断并抑制这一作用。Abstract: Objective To explore whether estradiol could activate the mitogen-activated protein kinase (MAPK) pathway and its effect on the proliferation of endometrial cancer Ishikawa cells. Methods Endometrial cancer Ishikawa cells were divided into three groups: estradiol (E2) group, U0126(MAPK inhibitor)+E2 group and control group. The expression of MEK1/2 and ERK1/2 mRNA were determined by qRT-PCR. The activation states of p-ERK1/2 and p-MEK1/2 protein were analyzed by Western blot. Flow cytometry was used to examine the cell cycle. Colony formation ability was detected by colony formation assay. Transwell assay was used to detect the cell migration. Results E2 significantly increased the expression of MEK1/2 and ERK1/2 mRNA(P=0.025, P=0.002). In the U0126+E2 group, U0126 significantly inhibited the up-regulation of MEK1/2, ERK1/2 mRNA expression induced by E2(P=0.000, P=0.000). E2 increased the activation level of p-MEK1/2, p-ERK1/2 protein (P=0.049, P=0.028）. In the U0126+E2 group, U0126 significantly inhibited the up-regulation of p-MEK1/2 and p-ERK1/2 protein activation levels induced by E2 (P=0.018, P=0.003). Compared with the U0126+E2 group and control group, the cells at G1 stage were less. the colony forming rate was lower and the cells migration ability was higher in E2 group (P=0.017, P=0.009, P=0.000). Conclusion Estradiol could activate MAPK pathway and promote the development of endometrial cancer cells. However, MEK inhibitor could block and inhibit this effect.
-
Key words:
- Endometrial adenocarcinoma /
- Estradiol(E2) /
- MAPK pathway
-
-
[1] Kim SK，Novak RF. The role of intracellular signaling in insulinmediated regulation of drug metabolizing enzyme gene and protein expression[J]. Pharmacol Ther, 2007, 113(1): 88-120. [2] Song Y, Dai F, Zhai D, et al. Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways[J]. Angiogenesis, 2012, 15(3): 42 1-32. [3] Dixon KM, Lui GY, Kovacevic Z, et al. Dp44mT targets the AKT, TGF-beta and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells[J]. Br J Cancer, 2013, 108(2): 409-19. [4] Lu YQ, Jiang S, Zhang JQ, et al. Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells[J]. Zhonghua Fu Chan Ke Za Zhi, 2014, 49 (12): 925-31. [ 卢燕琼, 蒋斯, 张洁清. 雌二醇诱导子宫内膜癌 细胞产生的VEGF和bFGF对MAPK通路的影响[J]. 中华妇产科 杂志, 2014, 49(12): 925-31.] [5] Lecanda J, Parekh TV, Gama P, et al. Transforming growth factorbeta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium[J]. Cancer Res, 2007, 67(3): 1007-18. [6] Acconcia F, Barnes CJ, Kumar R. Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells[J]. Endocrinology, 2006, 147(3): 1203-12. [7] Sun Y, Wang C, Yang H, et al. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRgamma through AKT and ERK1/2[J]. Eur J Cancer Prev, 20 14, 23(5): 418-24. [8] Brinkkoetter PT, Olivier P, Wu JS, et al. Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells[J]. J Clin Invest, 2009, 119(10): 3089-101. [9] Treeck O, Diedrich K, Ortmann O. The activation of an extracellular signal-regulated kinase by oestradiol interferes with the effects of trastuzumab on HER2 signalling in endometrial adenocarcinoma cell lines[J]. Eur J Cancer, 2003, 39(9): 1302-9. [10] Thomas RS, Sarwar N, Phoenix F, et al. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity[J]. J Mol Endocrinol, 2008, 40(4): 173-84. [11] Suga S, Kato K, Ohgami T, et al. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer[J]. Gynecol Oncol, 2007, 10 5(2): 341-50.
计量
- 文章访问数: 1338
- HTML全文浏览量: 376
- PDF下载量: 383
下载:
